CTOs on the Move

Cynosure

www.cynosure.com

 
Cynosure develops and markets laser and light-based aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, liquefy and remove unwanted fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus and ablate sweat glands. Cynosure`s product portfolio is composed of a broad range of energy sources including Alexandrite, diode, Nd: YAG, picosecond, pulse dye, and Q-switched lasers and intense pulsed light. Cynosure sells its products globally under the Cynosure, Palomar and ...
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details
Garrett Germon
VP, Global HR Operations & Integration Profile
Pamela Baxter
Chief Information Officer Profile

Similar Companies

Arbor Surgical Technologies

Arbor Surgical Technologies is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Doctor Diabetic Supply

Doctor Diabetic Supply is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Instromedix dba: LifeWatch

Instromedix dba: LifeWatch is a Des Plaines, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cameron Miller

Cameron Miller is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vicarious Surgical

At Vicarious Surgical we are revolutionizing the field of surgical robotics. We seek to improve the lives of patients, enhance the ability of surgeons, and expand worldwide access to high-quality care through the use of surgical robotics. We have reimagined what is possible by building a human-like surgical robot and combining it with the world`s first virtual-reality surgical camera to allow surgeons to perform minimally-invasive surgery with the ease of an open procedure.